Pediatrix Medical
215 hedge funds and large institutions have $1.16B invested in Pediatrix Medical in 2023 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 78 increasing their positions, 81 reducing their positions, and 21 closing their positions.
354% more call options, than puts
Call options by funds: $481K | Put options by funds: $106K
10% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 21
0% more funds holding
Funds holding: 214 → 215 (+1)
4% less repeat investments, than reductions
Existing positions increased: 78 | Existing positions reduced: 81
2.84% less ownership
Funds ownership: 100.88% → 98.04% (-2.8%)
7% less capital invested
Capital invested by funds: $1.25B → $1.16B (-$90.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
+$8.77M |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
+$7.94M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.62M |
| 4 |
Goldman Sachs
New York
|
+$5.08M |
| 5 |
D.E. Shaw & Co
New York
|
+$4.32M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$27.8M |
| 2 |
EARNEST Partners
Atlanta,
Georgia
|
-$17.4M |
| 3 |
New York State Common Retirement Fund
Albany,
New York
|
-$17.1M |
| 4 |
Pacer Advisors
Malvern,
Pennsylvania
|
-$12.4M |
| 5 |
Millennium Management
New York
|
-$1.92M |
MD Hedge Fund Activity: Q2 2023 in Review
215 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Pediatrix Medical (MD) for Q2 2023, worth a combined $1.16B — down 7.2% from $1.25B a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new MD positions and 21 closed out — a net gain of 2 holders — while 78 added to existing stakes and 81 trimmed.
The largest buyer was Segall Bryant & Hamill, adding an estimated $8.77M. The largest seller was ArrowMark Colorado Holdings, cutting an estimated $27.8M.
- 215 institutional investors held Pediatrix Medical (MD) as of Q2 2023, up from 214 in Q1 2023.
- Funds reported $1.16B of Pediatrix Medical stock for Q2 2023, down 7.2% quarter-over-quarter.
- 23 funds opened new Pediatrix Medical positions in Q2 2023 and 21 closed out, a net change of +2 holders.
- The largest Pediatrix Medical buyer in Q2 2023 was Segall Bryant & Hamill, an estimated $8.77M added.
- The largest Pediatrix Medical seller in Q2 2023 was ArrowMark Colorado Holdings, an estimated $27.8M sold.
Based on aggregated 13F filings for Q2 2023.